Regulation of the Small GTPase Rap1 and Extracellular Signal-regulated Kinases by the Costimulatory Molecule CTLA-4

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2005 May 5

PMID 15870282

Citations 24

Authors

Tara J Dillon

Kendall D Carey

Scott A Wetzel

David C Parker

Philip J S Stork

Affiliations

Soon will be listed here.

Abstract

The mitogen-activated protein kinase extracellular signal-regulated kinase (ERK) is activated following engagement of the T-cell receptor and is required for interleukin 2 (IL-2) production and T-cell proliferation. This activation is enhanced by stimulation of the coreceptor CD28 and inhibited by the coreceptor CTLA-4. We show that the small G protein Rap1 is regulated in the opposite manner; it is inhibited by CD28 and activated by CTLA-4. Together, CD3 and CTLA-4 activate Rap1 in a sustained manner. To delineate T-cell function in the absence of Rap1 activity, we generated transgenic mice expressing Rap1GAP1, a Rap1-specific GTPase-activating protein. Transgenic mice showed lymphadenopathy, and transgenic T cells displayed increased ERK activation, proliferation, and IL-2 production. More significantly, the inhibitory effect of CTLA-4 on T-cell function in Rap1GAP1-transgenic T cells was reduced. We demonstrate that CTLA-4 activates Rap1, and we propose that intracellular signals from CTLA-4 antagonize CD28, at least in part, at the level of Rap1.

Citing Articles

The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis.

de Sauvage M, Torrini C, Nieblas-Bedolla E, Summers E, Sullivan E, Zhang B Neuro Oncol. 2023; 26(5):889-901.

PMID: 38134951 PMC: 11066918. DOI: 10.1093/neuonc/noad248.

Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy.

Smith P, Piadel K, Dalgleish A Vaccines (Basel). 2021; 9(12).

PMID: 34960140 PMC: 8708201. DOI: 10.3390/vaccines9121392.

Motility Dynamics of T Cells in Tumor-Draining Lymph Nodes: A Rational Indicator of Antitumor Response and Immune Checkpoint Blockade.

Kanda Y, Okazaki T, Katakai T Cancers (Basel). 2021; 13(18).

PMID: 34572844 PMC: 8465463. DOI: 10.3390/cancers13184616.

Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.

Tekguc M, Wing J, Osaki M, Long J, Sakaguchi S Proc Natl Acad Sci U S A. 2021; 118(30).

PMID: 34301886 PMC: 8325248. DOI: 10.1073/pnas.2023739118.

Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8 T cells.

Kumar S, Singh S, Viswakarma N, Sondarva G, Nair R, Sethupathi P J Immunother Cancer. 2020; 8(2).

PMID: 32759234 PMC: 7410077. DOI: 10.1136/jitc-2019-000494.

References

Vijayakrishnan L, Slavik J, Illes Z, Greenwald R, Rainbow D, Greve B . An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity. 2004; 20(5):563-75. DOI: 10.1016/s1074-7613(04)00110-4. View

Daumke O, Weyand M, Chakrabarti P, Vetter I, Wittinghofer A . The GTPase-activating protein Rap1GAP uses a catalytic asparagine. Nature. 2004; 429(6988):197-201. DOI: 10.1038/nature02505. View

Okumura N, Okada M, Nakagawa H . Depolarization-induced tyrosine phosphorylation in PC12h cells. J Biochem. 1994; 116(2):346-50. DOI: 10.1093/oxfordjournals.jbchem.a124530. View

Walunas T, Lenschow D, Bakker C, Linsley P, Freeman G, Green J . CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994; 1(5):405-13. DOI: 10.1016/1074-7613(94)90071-x. View

Krummel M, Allison J . CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995; 182(2):459-65. PMC: 2192127. DOI: 10.1084/jem.182.2.459. View

Tivol E, Borriello F, Schweitzer A, Lynch W, Bluestone J, Sharpe A . Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995; 3(5):541-7. DOI: 10.1016/1074-7613(95)90125-6. View

Whitehurst C, Geppert T . MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J Immunol. 1996; 156(3):1020-9. View

Krummel M, Allison J . CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med. 1996; 183(6):2533-40. PMC: 2192613. DOI: 10.1084/jem.183.6.2533. View

Krummel M, Sullivan T, Allison J . Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int Immunol. 1996; 8(4):519-23. DOI: 10.1093/intimm/8.4.519. View

10.

Tivol E, Boyd S, McKeon S, Borriello F, Nickerson P, Strom T . CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol. 1997; 158(11):5091-4. View

11.

Chambers C, Cado D, Truong T, Allison J . Thymocyte development is normal in CTLA-4-deficient mice. Proc Natl Acad Sci U S A. 1997; 94(17):9296-301. PMC: 23164. DOI: 10.1073/pnas.94.17.9296. View

12.

Zhao H, Li Y, Fucini R, Ross S, Pessin J, Koretzky G . T cell receptor-induced phosphorylation of Sos requires activity of CD45, Lck, and protein kinase C, but not ERK. J Biol Chem. 1997; 272(34):21625-34. DOI: 10.1074/jbc.272.34.21625. View

13.

Boussiotis V, Freeman G, Berezovskaya A, Barber D, Nadler L . Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science. 1997; 278(5335):124-8. DOI: 10.1126/science.278.5335.124. View

14.

Calvo C, Amsen D, Kruisbeek A . Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J Exp Med. 1997; 186(10):1645-53. PMC: 2199134. DOI: 10.1084/jem.186.10.1645. View

15.

Iezzi G, Karjalainen K, Lanzavecchia A . The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity. 1998; 8(1):89-95. DOI: 10.1016/s1074-7613(00)80461-6. View

16.

Reedquist K, Bos J . Costimulation through CD28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap1 in human T lymphocytes. J Biol Chem. 1998; 273(9):4944-9. DOI: 10.1074/jbc.273.9.4944. View

17.

Lee K, Chuang E, Griffin M, Khattri R, Hong D, Zhang W . Molecular basis of T cell inactivation by CTLA-4. Science. 1998; 282(5397):2263-6. DOI: 10.1126/science.282.5397.2263. View

18.

Mandelbrot D, McAdam A, Sharpe A . B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med. 1999; 189(2):435-40. PMC: 2192978. DOI: 10.1084/jem.189.2.435. View

19.

Fraser J, Rincon M, McCoy K, Le Gros G . CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells. Eur J Immunol. 1999; 29(3):838-44. DOI: 10.1002/(SICI)1521-4141(199903)29:03<838::AID-IMMU838>3.0.CO;2-P. View

20.

Nakaseko C, Miyatake S, Iida T, Hara S, Abe R, Ohno H . Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J Exp Med. 1999; 190(6):765-74. PMC: 2195638. DOI: 10.1084/jem.190.6.765. View